SEARCH RESULTS FOR: "Tag: BIIB"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2021(1)
2020(5)
2019(16)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(3)
Analyst Downgrades(4)
Analyst Update(16)
Analyst Upgrades(5)
Buzz Stocks(27)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(5)
Stocks On the Move(12)
Technical Analysis(1)

1/29/2021 10:24 AM
Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.9% to trade at $291.00 this morning, after the Food and Drug Administration (FDA) extended the review period for Biogen's experimental Alzhe...
12/1/2020 11:57 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...
7/27/2020 10:36 AM
Pharmaceutical name Biogen Inc (NASDAQ:BIIB) is soaring today, up 4.2% to trade at $283.89, on a double upgrade from Morgan Stanley. The analyst lifted its rating to "overweight" from "underweight" a...
7/22/2020 10:06 AM
The shares of Biogen Inc (NASDAQ: BIIB) are up 1.8% at $285.23 this morning, after the multinational biotechnology company reported second-quarter profits of $10.26 per share on 3.68 billion in revenu...
7/8/2020 9:57 AM
Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.8% to trade at $289.18 this morning, after the company submitted a marketing application to the Food and Drug Administration (FDA) regarding...
 
Special Offers from Schaeffer's Trading Partners